The Zenith® p-Branch® Pivotal Study is a clinical trial approved by FDA to study the safety and effectiveness of the Zenith® p-Branch® endovascular graft in combination with the Atrium iCAST™ covered stents in the treatment of abdominal aortic aneurysms.
CRITERIA LIST/ QUALIFICATIONS:
Pararenal or juxtarenal AAA ≥5.0 cm in diameter or 2 times the normal aortic diameter.
Pararenal or juxtarenal AAA with history of growth ≥0.5 cm/year.
Saccular aneurysm with aortic diameter greater than 1.5 times the normal aortic diameter that is deemed to be at risk for rupture based upon physician interpretation.